Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$94.53 - $120.55 $5.11 Million - $6.51 Million
-54,007 Reduced 90.53%
5,647 $670,000
Q1 2024

May 15, 2024

SELL
$86.88 - $112.48 $199,302 - $258,029
-2,294 Reduced 3.7%
59,654 $6.4 Million
Q4 2023

Feb 14, 2024

BUY
$81.08 - $119.29 $5.02 Million - $7.39 Million
61,948 New
61,948 $6.18 Million
Q1 2023

May 15, 2023

BUY
$153.15 - $198.21 $367,713 - $475,902
2,401 New
2,401 $396,000
Q4 2021

Feb 14, 2022

SELL
$220.96 - $247.44 $454,293 - $508,736
-2,056 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$186.8 - $260.0 $384,060 - $534,560
2,056 New
2,056 $479,000
Q2 2021

Aug 13, 2021

SELL
$190.83 - $215.73 $550,926 - $622,812
-2,887 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$197.58 - $222.54 $570,413 - $642,472
2,887 New
2,887 $593,000
Q3 2020

Nov 16, 2020

SELL
$177.7 - $200.24 $2.96 Million - $3.34 Million
-16,671 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$172.31 - $230.89 $2.82 Million - $3.78 Million
16,373 Added 5494.3%
16,671 $3.07 Million
Q1 2020

May 15, 2020

BUY
$160.04 - $216.15 $47,691 - $64,412
298 New
298 $60,000
Q3 2019

Nov 14, 2019

SELL
$154.21 - $257.38 $2.77 Million - $4.62 Million
-17,945 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$212.8 - $251.91 $731,606 - $866,066
3,438 Added 23.7%
17,945 $4.52 Million
Q1 2019

May 14, 2019

SELL
$221.09 - $253.28 $15.3 Million - $17.6 Million
-69,335 Reduced 82.7%
14,507 $3.47 Million
Q4 2018

Feb 14, 2019

SELL
$213.13 - $281.01 $14.8 Million - $19.5 Million
-69,418 Reduced 45.29%
83,842 $19.3 Million
Q3 2018

Nov 14, 2018

BUY
$265.5 - $307.63 $40.7 Million - $47.1 Million
153,260 New
153,260 $43.3 Million

Others Institutions Holding ICUI

About ICU MEDICAL INC


  • Ticker ICUI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 23,899,400
  • Market Cap $4.01B
  • Description
  • ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...
More about ICUI
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.